arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Ingevity Corp

NGVT
$63.83 ▼ -9.89 (-13.42%) at close
Materials ·Chemicals & Allied Products ·USChemicals & Allied Products
48 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
58
Health
Fair
Neutral
auto_awesome

Analytical Summary

Ingevity Corp shows mixed fundamentals. On the positive side, Operating Margin (%) remains strong. Consider comparing against peers in the Materials sector before making investment decisions.

Market Cap $2.2B
Dividend Yield —
Revenue Growth -14.0% ↘
Op. Margin None
ROIC None
FCF / Share $-0.40 ↘
Trailing P/E 62.6x
Price / Book 46.9x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

48-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$314.10M
↓ -14.0% —
Net Income Profit after all expenses
$59.80M
↑ +191.7% —
Operating Margin Operating profit as % of sales
52.2%
↑ +78.6% 91th
FCF / Share Free cash flow per share
$-0.40
↓ -601.3% —
trending_up

Bullish Indicators

  • Operating Margin (%)Operating Margin (%) is in the top quartile
warning

Bearish Risks

  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑
65
Financial Health ↓
74
Cash Quality
7

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 13 years · 48 quarters